
Telmitif 80 Tablet
Marketer
Positif Life sciences
Salt Composition
Telmisartan (80mg)
Overview Telmitif 80 Tablet
CardioGuard 80mg tablets manage hypertension and congestive heart failure. Reduced blood pressure minimizes the risk of future strokes and myocardial infarctions. This medication also safeguards kidney function in diabetic patients. CardioGuard 80mg may be administered independently or alongside other medications, with or without food, at any time of day. Consistent daily dosing maximizes therapeutic effect; continued use is crucial even with controlled blood pressure or well-being, as untreated hypertension can worsen. This widely prescribed medication boasts a favorable long-term safety profile. Lifestyle modifications, such as weight loss, regular exercise, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as advised by your physician), complement its efficacy. Generally well-tolerated, potential side effects include hypotension. Report any adverse effects to your doctor; dosage adjustment or alternative medication may be necessary. Prior to commencing treatment, disclose any kidney or liver conditions, and pregnant or lactating individuals should seek medical counsel. Regular monitoring of kidney function, blood pressure, and serum potassium levels will be conducted during treatment.
Uses of Telmitif 80 Tablet
Managing high blood pressure | Addressing heart failure | Reducing fever | Preventing strokes and myocardial infarction
Major Benefits of Telmitif 80 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmitif 80 Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Telmitif 80 Tablet:
- Diarrhea
- Upper respiratory tract infection
- Back pain
- Sinus inflammation
- Skin ulcer
- Intermittent claudication
How to use Telmitif 80 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitif 80 Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Telmitif 80 Tablet works:
Telmitif 80mg tablets function as an angiotensin receptor blocker, or ARB. By inhibiting a vasoconstricting substance, they promote vasodilation, thereby reducing blood pressure. This improved blood flow enhances organ perfusion and cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Telmitif 80 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telmitif 80 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on Telmitif 80 Tablet use while breastfeeding is absent. Seek medical advice.
DrivingUNSAFE
Taking Telmitif 80 Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmitif 80 Tablets, as dose modification may be necessary. It's crucial to discuss this with your physician. Disclosure of pre-existing kidney conditions is essential. Your doctor might recommend routine monitoring of blood pressure, creatinine, and potassium levels during treatment.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Telmitif 80mg tablets, potentially requiring dose modification. Physician consultation is advised. Telmitif 80mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Telmitif 80 Tablet :
Omit any missed Telmitif 80 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Telmitif 80 Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Therapy | Heart |
